Glenmark कडून Nitric Oxide Nasal Spray लॉन्च; प्रौढ कोविड 19 रूग्णांवर उपचार म्हणून वापर करण्यास ड्र्ग रेग्युलेटर कडून परवानगी

Glenmark कडून Nitric Oxide Nasal Spray लॉन्च करण्यात आली आहे. प्रौढ कोविड 19 रूग्णांवर उपचार म्हणून वापर करण्यास ड्र्ग रेग्युलेटर कडून परवानगी देण्यात आली आहे. ग्लेनमार्कला मॅन्युफॅक्चरिंग आणि मार्केटिंगसाठी परवानगी आहे.

ANI Tweet

Glenmark launches Nitric Oxide Nasal Spray(FabiSpray®)in India for treatment of adult patients with #COVID19,in partnership with SaNOtize. It received manufacturing-marketing approval from India’s drug regulator for Nitric Oxide Nasal Spray as part of accelerated approval process pic.twitter.com/MVTLu1xZoK

— ANI (@ANI) February 9, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)

(The above story first appeared on LatestLY on Feb 09, 2022 10:27 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).